title: Mutation of a C-terminal motif affects Kaposi's sarcoma-associated herpesvirus ORF57 RNA binding, nuclear trafficking, and multimerization.
abstract: The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is essential for virus lytic replication. ORF57 regulates virus gene expression at multiple levels, enhancing transcription, stability, nuclear export, and translation of viral transcripts. To enhance the nuclear export of viral intronless transcripts, ORF57 (i) binds viral intronless mRNAs, (ii) shuttles between the nucleus, nucleolus, and the cytoplasm, and (iii) interacts with multiple cellular nuclear export proteins to access the TAP-mediated nuclear export pathway. We investigated the implications on the subcellular trafficking, cellular nuclear export factor recruitment, and ultimately nuclear mRNA export of an ORF57 protein unable to bind RNA. We observed that mutation of a carboxy-terminal RGG motif, which prevents RNA binding, affects the subcellular localization and nuclear trafficking of the ORF57 protein, suggesting that it forms subnuclear aggregates. Further analysis of the mutant shows that although it still retains the ability to interact with cellular nuclear export proteins, it is unable to export viral intronless mRNAs from the nucleus. Moreover, computational molecular modeling and biochemical studies suggest that, unlike the wild-type protein, this mutant is unable to self-associate. Therefore, these results suggest the mutation of a carboxy-terminal RGG motif affects ORF57 RNA binding, nuclear trafficking, and multimerization.
authors: Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.
authors: Adam
authors: A
authors: Taylor
authors: Brian R
authors: BR
authors: Jackson
authors: Marko
authors: M
authors: Noerenberg
authors: David J
authors: DJ
authors: Hughes
authors: James R
authors: JR
authors: Boyne
authors: Mark
authors: M
authors: Verow
authors: Mark
authors: M
authors: Harris
authors: Adrian
authors: A
authors: Whitehouse
references: J Virol. 2001 Jul;75(13):6033-41
references: 11390605
references: Front Biosci (Landmark Ed). 2009 Jan 01;14(4):1516-28
references: 19273144
references: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15190-5
references: 17005724
references: J Biol Chem. 2006 Sep 22;281(38):28365-78
references: 16829516
references: J Virol. 2008 Mar;82(6):2792-801
references: 18184716
references: Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3386-91
references: 18287003
references: Science. 1994 Dec 16;266(5192):1865-9
references: 7997879
references: J Gen Virol. 2007 Feb;88(Pt 2):405-410
references: 17251556
references: Oncogene. 2003 Aug 11;22(33):5150-63
references: 12910252
references: Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14937-42
references: 10611316
references: J Biol Chem. 2001 Jun 8;276(23):19905-12
references: 11278515
references: J Virol. 2009 Sep;83(17):8970-5
references: 19553338
references: Science. 2005 Sep 2;309(5740):1514-8
references: 16141059
references: Cell Cycle. 2010 Jul 15;9(14):2702-3
references: 20686356
references: Curr Biol. 2009 Dec 1;19(22):1918-24
references: 19836239
references: Clin Microbiol Infect. 2006 Feb;12(2):110-7
references: 16441447
references: EMBO Rep. 2009 Mar;10(3):231-8
references: 19229283
references: J Gen Virol. 2000 Sep;81(Pt 9):2253-2265
references: 10950983
references: J Virol. 1998 Oct;72(10):8309-15
references: 9733875
references: J Cell Biol. 2002 Nov 25;159(4):579-88
references: 12438415
references: Front Biosci. 2008 May 01;13:3798-813
references: 18508475
references: Nat Protoc. 2008;3(6):1101-8
references: 18546601
references: Biochem J. 2008 Nov 1;415(3):345-51
references: 18729828
references: Front Biosci. 2008 May 01;13:5241-56
references: 18508584
references: J Gen Virol. 2009 Mar;90(Pt 3):596-601
references: 19218204
references: EMBO J. 2010 Jun 2;29(11):1851-64
references: 20436455
references: EMBO J. 2001 Oct 15;20(20):5769-78
references: 11598019
references: J Virol. 2002 Nov;76(22):11612-22
references: 12388722
references: Cell. 2009 Feb 20;136(4):688-700
references: 19239889
references: J Clin Invest. 2004 Jan;113(1):124-36
references: 14702116
references: J Gen Virol. 2009 Jun;90(Pt 6):1455-1460
references: 19264631
references: J Clin Invest. 2010 Apr;120(4):939-49
references: 20364091
references: RNA. 2003 Jul;9(7):881-91
references: 12810921
references: Front Biosci. 2008 Jan 01;13:2928-38
references: 17981766
references: J Virol. 1996 Nov;70(11):7445-53
references: 8892862
references: PLoS Pathog. 2008 Oct;4(10):e1000194
references: 18974867
references: J Virol. 2009 Jul;83(13):6727-38
references: 19369342
references: J Virol. 1997 Aug;71(8):5915-21
references: 9223481
references: J Biol Chem. 2009 Sep 18;284(38):26106-16
references: 19586903
references: J Virol. 2005 Apr;79(7):3949-61
references: 15767397
references: FEBS Lett. 2009 Nov 19;583(22):3549-56
references: 19850040
references: J Virol. 2007 Sep;81(18):9990-8
references: 17609285
references: Virology. 1999 May 10;257(2):341-51
references: 10329545
references: J Clin Invest. 1997 Nov 15;100(10):2606-10
references: 9366576
references: Microbiol Mol Biol Rev. 2003 Jun;67(2):175-212, table of contents
references: 12794189
references: Histochem Cell Biol. 2008 Jan;129(1):13-31
references: 18046571
references: PLoS Pathog. 2010 Mar 05;6(3):e1000799
references: 20221435
references: J Virol. 2002 Dec;76(24):12877-89
references: 12438613
references: Infect Agents Dis. 1996 Oct;5(4):215-22
references: 8884366
references: J Virol. 2002 Dec;76(23):11866-79
references: 12414929
references: J Gen Virol. 2004 Jan;85(Pt 1):147-153
references: 14718629